- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06073028
Model-based Cueing-as-needed for Walking in Parkinson's Disease (GAITPARK)
October 9, 2023 updated by: Emilie Hutin, Henri Mondor University Hospital
Correcting of the lack of regularity in steps is a key component of gait rehabilitation in Parkinson's disease.
The proposal is to introduce adaptive spatial auditory cueing (ASAC) based on verbal instruction "lengthen the step" automatically delivered when the stride length decreased below a predetermined threshold.
The present study compared the effect of usual rhythmic auditory cueing versus ASAC used during a walking training in Parkinson's disease.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Correcting of the lack of regularity in steps is a key component of gait rehabilitation in Parkinson's disease.
The proposal is to introduce adaptive spatial auditory cueing (ASAC) based on verbal instruction "lengthen the step" automatically delivered when the stride length decreased below a predetermined threshold.
The present study compared the effect of usual rhythmic auditory cueing versus ASAC used during a walking training in Parkinson's disease.
Fifteen patients with Parkinson's disease performed both interventions in randomized order, one week apart: a 20-minute walking training with rhythmic auditory cueing, in form of a metronome adjusted on 110% of the patient's own cadence, or ASAC delivered when the stride length is less than 110% of the patient's own stride length.
Assessment criteria were walking distance covered during the intervention, speed, step length, cadence, coefficients of variation of step length and step duration, and indexes of spatial and temporal asymmetry during a walking test before and just after the intervention.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Créteil, France
- Laboratoire Analyse et Restauration du Mouvement
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- the diagnosis of idiopathic PD based on the United Kingdom-Parkinson's Disease Society Brain Bank criteria;
- stage 2 or 3 on the Hoehn and Yahr scale;
- comfortable walking speed over 10 meters ≤ 1 m/s;
- ability to walk over 20 minutes without aids or antiparkinsonian medications;
- a stable antiparkinsonian medication regime;
- cognitive abilities to understand the verbal instructions for a walking test according to the investigator's judgment;
- written consent for the participation.
Exclusion Criteria:
- intercurrent disease other than PD, affecting gait;
- any intercurrent medical condition preventing them from participating in two consecutive gait training one week apart;
- medical diagnosis of hearing loss;
- non-affiliation to the social security regime.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Rhythmic auditory cueing
The rhythmic auditory cueing (RAC) is a constant stimulation ("bip" signal) delivered by a numeric metronome, which is adjusted on 110% of the patient's own cadence.
|
All subjects undergo two 20-minute gait trainings using two different kinds of auditory cueing (temporal or spatial), one week apart (D1 and D8).
|
Experimental: Adaptive spatial auditory cueing
Adaptive spatial auditory cueing (ASAC) is a verbal instruction stimulation delivered by an application when the stride length of the patient is less than a predetermined threshold, during two consecutive strides.
The instruction is given in the patient's native language, which is French: "allongez le pas" (i.e.
"lengthen the step").
The predetermined threshold is 110% of the patient's own stride length.
|
All subjects undergo two 20-minute gait trainings using two different kinds of auditory cueing (temporal or spatial), one week apart (D1 and D8).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Walking speed
Time Frame: Before and just after the intervention
|
Speed in free walking condition over 10 meters barefoot, without any assistance
|
Before and just after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hutin Emilie, PhD, HenriMondorHU
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2021
Primary Completion (Actual)
February 2, 2021
Study Completion (Actual)
February 1, 2022
Study Registration Dates
First Submitted
October 3, 2023
First Submitted That Met QC Criteria
October 3, 2023
First Posted (Actual)
October 10, 2023
Study Record Updates
Last Update Posted (Actual)
October 11, 2023
Last Update Submitted That Met QC Criteria
October 9, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GAITPARK
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on 20-minute gait training
-
The University of QueenslandUniversity of California, San Diego; University of SydneyCompletedCatastrophizing Coronavirus (COVID-19)Australia
-
The University of QueenslandUniversity of California, San Diego; University of SydneyCompletedPain, Chronic | Pain, IntractableAustralia
-
Barretos Cancer HospitalUnknown
-
Saglik Bilimleri UniversitesiCompleted
-
National Taiwan University HospitalCompletedUrodynamic Stress Incontinence
-
Acibadem UniversityUnknownCold | Muscle InjuryTurkey
-
Canterbury Christ Church UniversityCompletedMindfulness | Healthy PopulationUnited Kingdom
-
University of MalayaCompleted
-
Cairo UniversityCompleted
-
National Taiwan University HospitalRecruitingParkinson Disease | Gait Disorders, NeurologicTaiwan